Report overview
This Report focus on medications for type 2 diabetes.
People with type 2 diabetes are often given medications including insulin to help manage their blood glucose levels. Most of these medications are in the form of tablets, but some are given by injection. Tablets or injections are intended to be used in conjunction with healthy eating and regular physical activity, not as a substitute.
This report aims to provide a comprehensive presentation of the global market for Type 2 Diabetes Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Type 2 Diabetes Medication. This report contains market size and forecasts of Type 2 Diabetes Medication in global, including the following market information:
Global Type 2 Diabetes Medication Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Type 2 Diabetes Medication market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Biguanides Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Type 2 Diabetes Medication include AstraZeneca, Novartis, Novo Nordisk, Johnson & Johnson, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Type 2 Diabetes Medication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Type 2 Diabetes Medication Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Type 2 Diabetes Medication Market Segment Percentages, by Type, 2022 (%)
Biguanides
Sulphonylureas
Thiazolidinediones
Alpha-glucosidase Inhibitors
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
Insulins
Global Type 2 Diabetes Medication Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Type 2 Diabetes Medication Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Type 2 Diabetes Medication Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Type 2 Diabetes Medication Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Type 2 Diabetes Medication revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Type 2 Diabetes Medication revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Novartis
Novo Nordisk
Johnson & Johnson
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Merck
Sanofi
Pfizer
Astellas Pharma
Daiichi Sankyo
Biocon
Glenmark
Bayer AG
Takeda
Sun pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Type 2 Diabetes Medication, market overview.
Chapter 2: Global Type 2 Diabetes Medication market size in revenue.
Chapter 3: Detailed analysis of Type 2 Diabetes Medication company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Type 2 Diabetes Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
